• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Impax Laboratories Inc

+ Add to Watchlist

ILR:GR

24.771 EUR 0.310 1.27%

As of 10:50:23 ET on 11/21/2014.

Snapshot for Impax Laboratories Inc (ILR)

Open: 24.612 Day's Range: 24.612 - 25.275 Volume: 0
Previous Close: 24.461 52wk Range: 15.810 - 25.275 1-Yr Rtn: +45.27%

Stock Chart for ILR

No chart data available.
  • ILR:GR 25.225
  • 1D
  • 1M
  • 1Y
24.461
Interactive ILR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.0832
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.2750
Est. PEG Ratio 0.8719
Market Cap (M EUR) 1,764.90
Shares Outstanding (M) 71.25
30 Day Average Volume 10
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILR

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

George Frederick Wilkinson "Fred"President/CEOMichael J NestorPres:Impax Pharmaceuticals
Bryan M ReasonsSenior VP:Finance/CFOMark A SchlossbergSenior VP/Secy/General Counsel
More Company Profile & Key Executives for ILR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil